ATNM vs MRVL · rev $35.0M vs P/E 100, rev $8.19B
Actinium Pharmaceuticals Inc (ATNM) versus Marvell Technology Group Ltd (MRVL) — a side-by-side from cached financials, not a winner call.
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
Marvell Technology Group Ltd (MRVL) is a semiconductors company listed on NASDAQ. It is led by Matthew J. Murphy.
Latest reported ATNM revenue for 2026-06-30 was $35.0M. Net income was $22.4M. Revenue was up 38788.9% from 2025-09-30 to 2026-06-30. ATNM currently screens at market cap $33.9M.
Latest reported MRVL revenue for 2026-01-31 was $8.19B. Net income was $2.67B. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
ATNM currently screens at market cap $33.9M. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
Not investment advice. Open the ATNM and MRVL stock pages for the full models.
Not investment advice.